Why Attend?

Agenda
CLE

The annual Enforcement, Litigation, and Compliance Conference brings together industry, regulators, attorneys, litigators, academics, and consultants to discuss trends and issues in enforcement and compliance, the latest developments in both civil and criminal litigation, and recent cases and settlements. This year’s conference will be a virtual event, offering an opportunity to hear from and interact with top officials from FDA, DOJ, FTC, and other government agencies. As we move out of the COVID-19 pandemic, come hear from your peers about how they are staying compliance and inspection ready as FDA ramps back up inspections, what companies need to do to plan for and manage enforcement risk, trends in criminal and civil litigation, and government priorities for the new year.

Conference Highlights:

  • Hear about top issues, priorities, and goals for 2022 directly from ORA and FDA’s Center Compliance Directors
  • Gain practical tips and best practices on preparing for and managing enforcement and compliance risk in a post-COVID era
  • Learn about trends in government and private litigation, and what happens post-emergency and enforcement discretion periods

 

Register

 

Industry & Firms

$1199
  • +$200 for non-members

Non-Profit

$899
  • +$100 for non-members

Government

$899
  • +$100 for non-members

Academic

$899
  • +$100 for non-members

Student

$99

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.

You can transfer your registration to another person at your organization for no cost by notifying us of the change. If you notify FDLI in writing at least five business days prior to the meeting, you can cancel your registration for a full refund (less a $75 fee). Refunds will be applied against the original form of payment.  

Our event policies are listed here. If you should have any further questions, please contact us at [email protected] or 800-956-6293.

Sponsors

Sponsorship opportunities are available. Please let us know if you would like more information.

 

Premier Sponsor

Gold Sponsor

 

Gold Sponsor

 

Gold Sponsor

Gold Sponsor

Gold Sponsor

Gold Sponsor

 

Gold Sponsor

 

Gold Sponsor

Silver Sponsor

Silver Sponsor

 

Silver Sponsor

 

Silver Sponsor

 

Silver Sponsor

 

Silver Sponsor

 

Silver Sponsor

Bronze Sponsor

 

Bronze Sponsor

 

 

Bronze Sponsor

Call for Proposals

FDLI and the Conference Planning Committee thanks those who participated in the Call for Proposals this summer. The input received from industry stakeholders helps us plan a timely program. If you submitted a proposal, you will be notified of the status of your proposal in September.

Planning Committee

Chair

Bob Rhoades,  Validant

Committee Members

Hannah R. Bornstein, Nixon Peabody LLP
Adrienne Franco Busby, Faegre Drinker Biddle & Reath LLP
Philip Crooker, Parexel International Corporation
Maya Florence, Skadden, Arps, Slate, Meagher & Flom LLP
Elizabeth A. Gallenagh, Healthcare Distribution Alliance (HDA)
William Gould, Holland & Knight LLP
Dennis C. Gucciardo, Morgan, Lewis & Bockius LLP
Stephanie M. Haggerty, Pfizer, Inc.
Bryan M. Haynes, Troutman Pepper Hamilton Sanders LLP
Winston S. Kirton, Winston & Strawn LLP
Pete Leininger, King & Spalding LLP
Donnelly McDowell, Kelley Drye & Warren LLP
Anne K. Miller, Medtronic
John A. Murphy III, Biotechnology Innovation Organization
Ann Oxenham, OC, FDA
Allen Sayler, EAS Consulting Group
Lora J. Spencer, Reed Smith LLP
William Stellmach, Willkie Farr & Gallagher LLP
Frances Zipp, Lachman Consultants